1,919 results on '"Montastruc, Jean‐Louis"'
Search Results
2. Association of antidepressants plus antithrombotics and bleeding risk: a pharmacovigilance study
3. Tramadol and the risk of bleeding complications in patients on oral anticoagulants: a pharmacovigilance study
4. Safety of pitolisant: a study in the WHO international pharmacovigilance database
5. Adverse Drug Reactions, Iatrogenic Diseases, Drug Safety, and Pharmacovigilance: Importance and Interest for Patients and Their Physicians
6. Thirst and drugs: A study in the World Health Organization's pharmacovigilance database
7. Drug-induced hypohidrosis and anhidrosis: analysis of the WHO pharmacovigilance database 2000–2020
8. Poids atropinique et médicaments anticholinergiques : intérêt et application en pratique clinique chez la personne âgée
9. COVID-19 vaccines: A perspective from social pharmacology
10. Interest of a general practitioner pharmacovigilance network to provide drug information: A comparative study in France
11. Drug-induced parkinsonism: Revisiting the epidemiology using the WHO pharmacovigilance database
12. Drug-Induced Hearing Loss in Children: An Analysis of Spontaneous Reports in the French PharmacoVigilance Database
13. Blood pressure measurements after mRNA-SARS-CoV-2 tozinameran vaccination: a retrospective analysis in a university hospital in France
14. Drug identification by the patient: Perception of patients, physicians and pharmacists
15. Role of serotonin and norepinephrine transporters in antidepressant-induced arterial hypertension: a pharmacoepidemiological-pharmacodynamic study
16. Paradoxical adverse drug reactions: descriptive analysis of French reports
17. A New Drug–Drug Interaction Between Hydroxychloroquine and Metformin? A Signal Detection Study
18. Fluoroquinolone-Induced Photosensitivity: A Chemical Fragment-Based Approach by a Case/Non-case Study in VigiBase®
19. Why Were More Than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?
20. Drug-induced osteoporosis/osteomalacia: analysis in the French and Spanish pharmacovigilance databases
21. Association between anticholinergic (atropinic) drug exposure and cognitive function in longitudinal studies among individuals over 50 years old: a systematic review
22. Does spontaneous adverse drug reactions’ reporting differ between different reporters? A study in Toulouse Pharmacovigilance Centre
23. Pharmacoepidemiology in pregnancy
24. What is pharmacoepidemiology? Definition, methods, interest and clinical applications
25. Hypertension and Covid-19 vaccines: are there any differences between the different vaccines? A safety signal
26. Drug-induced diseases: a worrying, neglected, preventable, serious and costly epidemic
27. QT prolongation and vortioxetine: a post-marketing study and comparison with other serotonin reuptake inhibitors
28. Authors’ Reply to Yu et al.: “Levothyrox® New and Old Formulations: Are They Switchable for Millions of Patients?”
29. Authors’ Reply to Nicolas: “Why Were More than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?”
30. In utero drug exposure and hearing impairment in 2-year-old children A case-control study using the EFEMERIS database
31. Utilization and costs of HIV antiretroviral drugs in Europe during the last ten years: Impact of generic antiretroviral drugs on cost reduction
32. Drugs and Dupuytren’s disease: a pharmacovigilance study in VigiBase®
33. Peptic ulcers with ChEIs, NSAIDs.
34. Breast cancer and spironolactone: an observational postmarketing study
35. Antidepressants during pregnancy: a French drug utilisation study in EFEMERIS cohort
36. Levothyrox® New and Old Formulations: Are they Switchable for Millions of Patients?
37. Drug-Induced Anaphylaxis in a Vietnamese Pharmacovigilance Database: Trends and Specific Signals from a Disproportionality Analysis
38. Adverse Drug Reactions Involving Protein Kinase Inhibitors: A French Pharmacovigilance Database Study Comparing Safety in Younger and Older Patients (≥ 75 years) with Cancer
39. POMME: The New Cohort to Evaluate Long-Term Effects After Prenatal Medicine Exposure
40. Pour une utilisation optimale des associations fixes de médicaments
41. Effets indésirables « graves » du tramadol : bilan 2011–2015 de pharmacovigilance en France
42. Drugs and bruxism: a study in the World Health Organization’s pharmacovigilance database
43. Mortality and Antipsychotic Drug Use in Elderly Patients With Parkinson Disease in Nursing Homes
44. Drug-induced panic attacks: Analysis of cases registered in the French pharmacovigilance database
45. Connaissance des femmes en âge de procréer sur l’acide folique : des progrès à faire !
46. Apport de la visite d’assistants de recherche clinique aux cabinets de médecins généralistes sur la notification des effets indésirables médicamenteux
47. Drug information by public health and regulatory institutions: Results of an 8-country survey in Europe
48. Comment mesure-t-on le bénéfice net d’un traitement ?
49. How to measure the net benefit of treatment?
50. Pour une utilisation optimale des associations fixes de médicaments. Recommandations de prescription
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.